Aberrant expression of Per1 affects the pathological process of oral cancer by controlling the expression of matrix metalloproteinase-2 and the intracellular distribution of laminin receptors, Per1 deficiency via the AKT/mTOR pathway promotes OSCC progression (Li et al., 2016a). The gene discussed is PER1; the disease is lip and oral cavity carcinoma.